We are live on
!
Find out more
First Manhattan Portfolio holdings
AUM
$36.1B
1-Year Est. Return
11.5%
This Fund
S&P 500
This Quarter
Est. Return
-0.07%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$27.1B
AUM Growth
-$250M
(-0.91%)
Cap. Flow
+$8.92M
Cap. Flow
% of AUM
0.03%
Top 10 Holdings %
Top 10 Hldgs %
55.27%
Holding
1,748
New
132
Increased
271
Reduced
387
Closed
93
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPLI
People Inc
PPLI
|
+$92.9M |
| 2 |
Amazon
AMZN
|
+$62.6M |
| 3 |
Enanta Pharmaceuticals
ENTA
|
+$46.3M |
| 4 |
VMEO
Vimeo
VMEO
|
+$33.1M |
| 5 |
UnitedHealth
UNH
|
+$28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$49.9M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$43.5M |
| 3 |
Humana
HUM
|
+$36.6M |
| 4 |
Vipshop
VIPS
|
+$35.6M |
| 5 |
Brookfield
BN
|
+$24M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 41.6% |
| 2 | Technology | 16.13% |
| 3 | Healthcare | 10.46% |
| 4 | Consumer Discretionary | 9.11% |
| 5 | Communication Services | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
MDU Resources
MDU
$4.42B
| $7.86M | 0.03% |
697,075
+4,734
| +0.7% | +$56.7K |
|
177
Navigator Holdings
NVGS
$1.34B
| $7.57M | 0.03% |
850,624
+23,841
| +3% | +$219K |
|
178
HCA Healthcare
HCA
$83.5B
| $7.48M | 0.03% |
30,836
| – | – |
|
179
Immunocore
IMCR
$1.81B
| $7.34M | 0.03% |
+197,999
| New | +$6.68M |
|
180
Brookfield Infrastructure
BIPC
$5.12B
| $7.31M | 0.03% |
183,135
-4,010
| -2% | -$176K |
|
181
Intel
INTC
$504B
| $7.31M | 0.03% |
137,148
-18,562
| -12% | -$1.01M |
|
182
Kimberly-Clark
KMB
$35.6B
| $7.21M | 0.03% |
54,448
-26
| -0% | -$3.54K |
|
183
Ameriprise Financial
AMP
$46B
| $7.14M | 0.03% |
27,049
-600
| -2% | -$157K |
|
184
Xylem
XYL
$27.8B
| $7.06M | 0.03% |
57,069
-1,024
| -2% | -$132K |
|
185
iShares Core S&P 500 ETF
IVV
$875B
| $7.04M | 0.03% |
16,334
+14,268
| +691% | +$6.32M |
|
186
Texas Instruments
TXN
$260B
| $6.99M | 0.03% |
36,361
-99
| -0.3% | -$18.9K |
|
187
SLB Ltd
SLB
$70.6B
| $6.98M | 0.03% |
235,594
-120
| -0.1% | -$3.44K |
|
188
TransAlta
TAC
$4.46B
| $6.89M | 0.03% |
652,800
+91,850
| +16% | +$920K |
|
189
Diamondback Energy
FANG
$57.8B
| $6.86M | 0.03% |
72,475
-10,000
| -12% | -$803K |
|
190
Enterprise Products Partners
EPD
$83.9B
| $6.82M | 0.03% |
315,191
-5,944
| -2% | -$135K |
|
191
Illinois Tool Works
ITW
$79.7B
| $6.64M | 0.02% |
32,137
-153
| -0.5% | -$34.5K |
|
192
Idacorp
IDA
$8.28B
| $6.52M | 0.02% |
63,043
| – | – |
|
193
EOG Resources
EOG
$77.5B
| $6.47M | 0.02% |
80,634
+6,836
| +9% | +$498K |
|
194
Brookfield Renewable
BEPC
$6.13B
| $6.44M | 0.02% |
165,928
-2,805
| -2% | -$118K |
|
195
AT&T
T
$157B
| $6.44M | 0.02% |
315,671
-20,583
| -6% | -$432K |
|
|
UBA
196
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $6.43M | 0.02% |
339,465
-1,300
| -0.4% | -$24.8K |
|
|
WBA
197
DELISTED
Walgreens Boots Alliance
WBA
| $6.4M | 0.02% |
136,015
-3,485
| -2% | -$168K |
|
198
MainStreet Bancshares
MNSB
$164M
| $6.27M | 0.02% |
261,389
+4,715
| +2% | +$111K |
|
199
Portland General Electric
POR
$6.06B
| $6.26M | 0.02% |
133,165
-7,880
| -6% | -$388K |
|
200
Artesian Resources
ARTNA
$350M
| $6M | 0.02% |
157,232
-264
| -0.2% | -$10.2K |
|
Similar funds
SAM
First Manhattan's Q3 2021 Portfolio in Review
As of Q3 2021, First Manhattan held 1,748 positions worth $27.1B, down 0.91% from $27.4B the previous quarter. Its ten largest holdings account for 55% of the portfolio.
First Manhattan's Q3 2021 filing shows 132 new, 271 increased, 387 reduced and 93 closed positions. Its largest new stake was Immunocore: 197,999 shares worth $7.34M. The largest sale was Amgen, an estimated $49.9M.
By sector, the portfolio is most concentrated in Financials at 42% of assets, down from 42% a quarter earlier, followed by Technology and Healthcare.
- First Manhattan's largest Q3 2021 buy was Immunocore: 197,999 shares worth $7.34M.
- First Manhattan added most to People Inc in Q3 2021, an estimated $92.9M increase.
- First Manhattan's biggest Q3 2021 reduction was Amgen, cutting an estimated $49.9M.
- First Manhattan fully exited Humana in Q3 2021, selling an estimated $36.6M.
- First Manhattan's ten largest holdings make up 55% of its $27.1B portfolio in Q3 2021.
- First Manhattan opened 132 new positions and closed 93 in Q3 2021.
- First Manhattan's portfolio value fell 0.91% quarter-over-quarter to $27.1B.
Based on First Manhattan's 13F filing for Q3 2021, filed 15 Nov 2021.